Literature DB >> 32894803

Clinical manifestations and maternal and perinatal outcomes with COVID-19.

Wei Li1, Nan Yu1, Qingling Kang1, Wanjiang Zeng1, Dongrui Deng1, Suhua Chen1, Ling Feng1, Jianli Wu1.   

Abstract

Coronavirus disease 2019 (COVID-19) is a novel type of highly contagious pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the COVID-19 outbreak unfolds, more and more pregnant women are infected with SARS-CoV-2, concerns have been raised about its clinical manifestations in pregnancy and the potential risk of vertical transmission from mother to fetus in pregnant women. Hence, in this review, we summarize the latest research progress related to COVID-19 epidemiology and the reported data of pregnant women with COVID-19 and discuss the clinical manifestations, treatments, maternal and perinatal outcomes, and intrauterine vertical transmission potential of such virus. Reported data suggest that symptoms in pregnant women are similar to those in other populations and that there is no evidence of vertical transmission from mother to child. In the meantime, considering the good prognosis of most of the infected mothers and infants and absence of serious obstetric complications in pregnant women with COVID-19, it is not recommended to give birth as soon as possible, and it is necessary to extend the gestational period reasonably.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID-19; maternal and perinatal outcomes; pregnancy; symptoms

Mesh:

Year:  2020        PMID: 32894803     DOI: 10.1111/aji.13340

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  3 in total

1.  COVID-19 infection among pregnant and non-pregnant women: Comparison of biochemical markers and outcomes during COVID-19 pandemic, A retrospective cohort study.

Authors:  Muhammad Sohaib Asghar; Muhammad Ali Siddiqui; Sadia Iqbal; Muhammad Junaid Tahir; Farah Yasmin; Najeebullah Chughtai; Farmanullah Khan; Tooba Ahmed Kirmani; Iqra Lareeb
Journal:  Ann Med Surg (Lond)       Date:  2022-03-28

2.  Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic.

Authors:  Małgorzata Jerzak; Monika Szafarowska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-03-24       Impact factor: 3.831

3.  Special issue on COVID-19 and pregnancy: Consequences for maternal and neonatal health.

Authors:  Surendra Sharma; Irina Burd; Aihua Liao
Journal:  Am J Reprod Immunol       Date:  2020-11       Impact factor: 3.777

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.